Monday 29 October 2018

Reuters Health Report: Shionogi aims to double flu-drug market with FDA-approved treatment

Reuters.com Newsletter

Shionogi aims to double flu-drug market with FDA-approved treatment

Japan's Shionogi & Co Ltd aims to double the global market for flu treatment with its drug Xofluza, the first flu drug approved by the U.S. Food and Drug Administration agency in nearly 20 years, its chief executive said.

FDA approves TherapeuticsMD's menopause drug

The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.

Drugmakers tout new medicines as eye disease battle intensifies

Switzerland's Roche and Novartis and other drugmakers are touting new treatments for a blindness-causing disease that hits millions of older people, as patent expiries are set to open up one of medicine's most lucrative markets.

Takeda proposes sale of Shire drug to gain European approval

Takeda Pharmaceutical Co Ltd has proposed to European regulators it could sell a Shire treatment in development due to concerns of overlap in inflammatory bowel disease treatments and its own drug Entyvio as it seeks clearance for the two companies' merger.

Novartis, Pfizer join forces on potentially lucrative fatty liver disease

Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics.

China reports new African swine fever in Hunan province

China's agricultural ministry reported on Sunday a new outbreak of African swine fever in Changde city of central Hunan province, where 99 pigs were killed and 106 were sick.

Eighth child dies at New Jersey center hit by viral outbreak

An eighth child has died at a New Jersey rehabilitation center where 23 people have been infected in a deadly viral outbreak, state health officials said on Friday.

Time, staffing top obstacles to sustaining school gardens

(Reuters Health) - Lack of time and staff support are the two biggest barriers to school garden success, according to a study published in the American Journal of Public Health.

Few smokers know about added sugar in cigarettes

(Reuters Health) - Very few smokers know there is sugar added to cigarettes, a new survey suggests.

Abbott, AbbVie settle TriCor marketing case for $25 million

Abbott Laboratories and AbbVie Inc will pay a total of $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.

Mindfulness meditation may reduce anxiety with breast biopsy

(Reuters Health) - A brief session of guided mindfulness-based meditation may help women undergoing a stereotactic breast biopsy to feel less anxious, a small study suggests.

Related Videos

Singer Sinead O'Connor converts to Islam

INSIGHT: Pumpkin party at London Zoo

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS